Physician profile
Allen T Bui
NPI 1285014688
$18,693.19
in general payments reported to CMS, 2019-2025
30 companies · $2,966 in 2025
The $2,966 reported for 2025 was more than what 78% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,978 · 2020: $1,207 · 2021: $703 · 2022: $7,573 · 2023: $1,761 · 2024: $505 · 2025: $2,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840 · Travel and Lodging: $2,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,839.63 |
| Travel and Lodging | $2,392.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $6,500.24 | 2021-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $2,301.37 | 2021-2025 | Endurant Iis, In.Pact Admiral, Concertotm |
| Silk Road Medical, INC. | $2,244.75 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,920.81 | 2019-2023 | Gore Tag Thoracic Endoprosthesis |
| Cook Medical LLC | $1,823.03 | 2019-2025 | Rosen, Zilver Ptx, Cook |
| Medtronic Vascular, INC. | $1,801.51 | 2019-2020 | |
| Boston Scientific Corporation | $572.33 | 2019-2025 | General - Vascular Intervention, Varithena Administration Pack, Eluvia |
| Shockwave Medical, INC | $289.98 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $256.17 | 2021-2022 | |
| Terumo Medical Corporation | $163.61 | 2021-2025 | Angio-Seal |
| Bard Peripheral Vascular, INC. | $116.39 | 2022 | |
| Kerecis Limited | $92.06 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Inari Medical, INC. | $76.74 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $53.11 | 2021-2022 | |
| Argon Medical Devices, INC. | $52.78 | 2023-2024 | Cleaner, Clot Management |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $47.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Smith+Nephew, INC. | $46.59 | 2021-2024 | Pico 14 |
| Surmodics, INC. | $43.28 | 2022-2024 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
| Artivion, INC. | $39.10 | 2022-2024 | Vascular |
| Sirtex Medical INC | $35.64 | 2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Truvic Medical, INC. | $35.30 | 2022 | |
| Cvrx, INC. | $33.81 | 2023 | Barostim Neo System |
| Abbott Laboratories | $29.98 | 2025 | Esprit |
| Becton, Dickinson and Company | $24.42 | 2023 | Venclose Maven Catheter |
| Kci USA, INC. | $21.00 | 2019 | |
| Sanara Medtech INC. | $18.93 | 2022 | |
| Humacyte Global, INC. | $15.90 | 2025 | Symvess |
| Lemaitre Vascular, INC. | $13.34 | 2023 | Artegraft Vascular Graft |
| Getinge USA Sales, LLC | $12.64 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $10.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.